» Articles » PMID: 30604051

An Update on Cannabis Use Disorder with Comment on the Impact of Policy Related to Therapeutic and Recreational Cannabis Use

Overview
Specialties Neurology
Psychiatry
Date 2019 Jan 4
PMID 30604051
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Confusion and controversy related to the potential for cannabis use to cause harm, or alternatively to provide benefit, continues globally. This issue has grown in intensity and importance with the increased recognition of the public health implications related to the escalation of the legalization of cannabis and cannabinoid products. This selective overview and commentary attempt to succinctly convey what is known about one potential consequence of cannabis use, the development of cannabis use disorder (CUD). Such knowledge may help guide a reasonable and objective public health perspective on the potential impact of cannabis use and CUD. Current scientific data and clinical observation strongly support the contention that cannabis use, like the use of other substances such as alcohol, opioids, stimulants, and tobacco, can develop into a use disorder (addiction) with important clinical consequences. Epidemiological data indicate that the majority of those who use cannabis do not have problems related to their use, but a substantial subset (10-30%) do report experiencing symptoms and consequences consistent with a CUD. Treatment seeking for CUD comprises a substantial proportion of all substance use treatment admissions, yet treatment response rates show much room for improvement. Changing cannabis policies related to its therapeutic and recreational use are likely to impact the development of CUD and its course; however, definitive data on such effects are not yet available. Clearly, the development of more effective prevention and treatment strategies is needed for those vulnerable to developing a CUD and for those with a CUD.

Citing Articles

Momentary mindfulness versus distraction coping messages to reduce cannabis craving among young adults: A microrandomized trial.

Stanger C, Anderson M, Xie H, Nnaka T, Budney A, Qian T Psychol Addict Behav. 2024; 39(2):200-211.

PMID: 39418443 PMC: 11875986. DOI: 10.1037/adb0001029.


Exploring Novel Pharmacotherapy Candidates for Cannabis Use Disorder: Uncovering Promising Agents on the Horizon by Mechanism of Action.

Alayoubi M, Henry B, Cahill C, Cooper Z Drugs. 2024; 84(11):1395-1417.

PMID: 39388076 PMC: 11602823. DOI: 10.1007/s40265-024-02098-1.


Current Status of Cannabis Legalization and Decriminalization Efforts in Nepal.

Pathak N, Dhungana S, Basyal B, Jha P, Shrestha S, Thapa P Subst Abuse Rehabil. 2024; 15:163-171.

PMID: 39267942 PMC: 11391128. DOI: 10.2147/SAR.S466728.


[Cannabis use and cannabis use disorders].

Hoch E, Preuss U Nervenarzt. 2024; 95(9):781-796.

PMID: 39134752 DOI: 10.1007/s00115-024-01722-5.


Investigating Substance Use as a Coping Strategy Among Adolescent Psychiatric Inpatients: A Comparative Analysis Before and During the COVID-19 Pandemic.

Thomas S, Thompson E, Peters J, Micalizzi L, Meisel S, Maron M Child Psychiatry Hum Dev. 2024; .

PMID: 38965169 PMC: 11698952. DOI: 10.1007/s10578-024-01731-0.


References
1.
Biener L, Siegel M . Tobacco marketing and adolescent smoking: more support for a causal inference. Am J Public Health. 2000; 90(3):407-11. PMC: 1446173. DOI: 10.2105/ajph.90.3.407. View

2.
Dewit D, Adlaf E, Offord D, Ogborne A . Age at first alcohol use: a risk factor for the development of alcohol disorders. Am J Psychiatry. 2000; 157(5):745-50. DOI: 10.1176/appi.ajp.157.5.745. View

3.
Degenhardt L, Hall W, Lynskey M . The relationship between cannabis use, depression and anxiety among Australian adults: findings from the National Survey of Mental Health and Well-Being. Soc Psychiatry Psychiatr Epidemiol. 2001; 36(5):219-27. DOI: 10.1007/s001270170052. View

4.
von Sydow K, Lieb R, Pfister H, Hofler M, Sonntag H, Wittchen H . The natural course of cannabis use, abuse and dependence over four years: a longitudinal community study of adolescents and young adults. Drug Alcohol Depend. 2001; 64(3):347-61. DOI: 10.1016/s0376-8716(01)00137-5. View

5.
Chaloupka F, Cummings K, Morley C, Horan J . Tax, price and cigarette smoking: evidence from the tobacco documents and implications for tobacco company marketing strategies. Tob Control. 2002; 11 Suppl 1:I62-72. PMC: 1766067. DOI: 10.1136/tc.11.suppl_1.i62. View